Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Chemoradiation With Weekly Cisplatin vs Paclitaxel/Carboplatin in Locally Advanced Head and Neck Squamous Cell Carcinoma
DRKS00012877Phase 3Not yet recruiting
- Sponsor
- Dr. Md Shuayb
- Start
- Aug 2017
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin, paclitaxel and carboplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Dr. Md Shuayb. Primary endpoints: Tumor response rate and Acute treatment-related toxicities. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
cisplatinpaclitaxelcarboplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on DRKS00012877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012877.